Appropriate patients.
| Indicated for KidneyIntelX | Not Indicated for KidneyIntelX | |
|---|---|---|
| KidneyIntelX is indicated for use as an aid to further assess the risk of progressive decline in kidney function within a period of up to 5 years in patients over the age of 21 with type 2 diabetes and existing chronic kidney disease | ||
| Patients with chronic kidney disease who have an estimated Glomerular Filtration Rate [eGFR] of 30-59 ml/min/1.73m2 [G3a, G3b] or an eGFR ≥ 60 with albuminuria [UACR] ≥ 30 mg/g. [A2, A3] | ||
| Diabetic patients who have not yet been diagnosed with chronic kidney disease | ||
| Patients who are taking ENBREL |
Indicated for KidneyIntelX
KidneyIntelX is indicated for use as an aid to further assess the risk of progressive decline in kidney function within a period of up to 5 years in patients over the age of 21 with Type 2 diabetes and existing chronic kidney disease.
Patients with chronic kidney disease who have an estimated Glomerular Filtration Rate [eGFR] of 30-59 ml/min/1.73 m2 [G3a, G3b] or an eGFR ≥ 60 with albuminuria [UACR] ≥ 30 mg/g. [A2, A3].
Not indicated for KidneyIntelX
Diabetic patients who have not yet been diagnosed with chronic kidney disease.
Patients who are taking ENBREL.